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Escherichia coliSeven homoisoﬂavonoids and one stilbenoid, 3-(4′-methoxybenzyl)-6,7-dihydroxy-5-methoxychroman-4-one
(1) which is new; 3-(4′-methoxybenzyl)-6-hydroxy-5,7-dimethoxychroman-4-one (2); 3-(4′-methoxybenzyl)-
5,7-dimethoxychroman-4-one (3); 3-(3′-hydroxy-4′-methoxybenzyl)-5,7-dimethoxychroman-4-one (4); 3-
(4′-methoxybenzylidene)-5,7-dihydroxy-6-methoxychroman-4-one (5); 3-(4′-hydroxybenzylidene)-5,7-
dihydroxy-6-methoxychroman-4-one (6); 3-(4′-hydroxybenzylidene)-5,7-dihydroxychroman-4-one (7)
and 4,3′,5′-trihydroxy-3-methoxystilbene (8), were isolated from the yellow inter-bulb deposits from Scilla
nervosa. The structures of these compounds were elucidated by 1D- and 2D-NMR and mass spectrometry.
A number of extracts, fractions and compounds tested displayed bacterostatic activity with MICs ranging be-
tween 0.156 and 1.250 mg/ml. Two extracts displayed signiﬁcantα-glucosidase inhibitory activity and a number
of extracts, fractions and compounds showed strong antioxidant activity with, compounds 1, 2 and 8 displaying
lower MECs than the positive control ascorbic acid (0.0156 mg/ml).
© 2013 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
Scilla nervosa (Burch.) Jessop [syn. Scilla rigidifolia Kunth,
Schizocarphus nervosus (Burch.) Van der Merwe] (Hyacinthaceae) is
an important traditional medicinal plant in Southern Africa. It is used
for conditions associated with infection, inﬂammation, pains (such as
rheumatic fever), as a laxative and the bulbs of S. nervosa are claimed
to enhance female fertility (Bangani et al., 1999; Silayo et al., 1999;
Louw et al., 2002; Bezabih et al., 2009; Du Toit et al., 2011). The plant it-
self grows up to 50 cm with a bulb up to 8 cm in diameter. The leaves
are lanceolate in shape with articulated vascular bundles with white
ﬂowers (Stedje, 1996).
Various organic crude extracts of the whole bulbs of S. nervosa
displayed anti-inﬂammatory and antimicrobial activities (Du Toit et
al., 2011) and phytochemical studies on the whole bulbs led to the
isolation of ﬁfteen homoisoﬂavonoids and four stilbenoids (Bangani
et al., 1999; Silayo et al., 1999). However, speciﬁc yellow deposits
(exudates) on the surface of the bulb layers are less well character-
ized. Phytochemical investigations previously conducted by our
group afforded ﬁve new homoisoﬂavonoids raising the total number
of homoisoﬂavonoids from the species to twenty (Bezabih et al.,
2009; Famuyiwa et al., 2012). Although ﬂavonoids are known toyiwa).
by Elsevier B.V. All rights reservedoccur as leaf surface exudates in certain plants (Midiwo et al.,
2002), this was the ﬁrst report of such a phenomenon on bulb leaves.
Generally, secondary metabolites especially from medicinal plants
have proven to be valuable sources of drugs in combating many
human conditions including microbial infections, metabolic diseases
and ailments related to age. More speciﬁcally, anti-oxidative properties
of these secondarymetabolites serve as an indicator for potential use in
the prevention or retardation of ageing processes, strokes, cancers and
other conditions related to oxidative stress (Krishnaiah et al., 2007;
Pandey and Rizvi, 2009), while α-glucosidase inhibitory properties
might have clinical applications in the treatment of diabetes (Tundis
et al., 2010) and HIV-infection particularly at the stage of viral entry
(Robina et al., 2004). This paper reports a new homoisoﬂavonoid isolat-
ed from the yellow inter-bulb surface deposits of S. nervosa and charac-
terizes various crude extracts, fractions and isolated compounds from
these exudates by providing a comprehensive bioactivity proﬁle.
2. Methodology
2.1. General experimental procedures
NMR spectra were measured on Bruker Avance DPX 300 and DRX
600 instruments using chloroform-d3 and acetone-d6 as solvents and
internal standard. HR EI-MS spectra were determined on a Waters
GCT-Premier spectrometer. Pre-coated silica gel 60 F254 TLC plates.
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visualized by spraying with vanillin-sulfuric acid solution.
2.2. Plant material
The bulbs of the plant, S. nervosa (Burch.) Jessop, were bought
from a herb vendor at a bus rank in Gaborone, Botswana and a corre-
sponding voucher specimen (SN 1977) was kept in the Herbarium
of the National Museum in Gaborone. The plant was identiﬁed by
Ms. Kelemogile Mathaka, the University of Botswana Herbarium cura-
tor based at the Department of Biology, Faculty of Science, University
of Botswana.
2.3. Extraction and isolation of compounds
2.3.1. Exudates
The layers of the air-dried bulbs of S. nervosa (1.5 kg) were peeled
and dipped in acetone for about ﬁve seconds one after the other to
wash off the yellow deposits of the inter-bulb surfaces to obtain an or-
ganic extract (AC). The solution was concentrated under reduced
pressure at about 35 °C to give a sticky brown residue which
was suspended in one liter 20% aqueous methanol. The aqueous
methanol was partitioned between n-hexane (200 ml × 5), chlo-
roform (200 ml × 5) and ethylacetate (200 ml × 5). The combined
n-hexane fraction (HF), combined chloroform fraction (CF), combined
ethylacetate fraction (EF) and the remaining aqueous methanol (MF)
were evaporated under reduced pressure at about 35 °C to give 2.4 g,
79.6 g, 6.9 g and 13.6 g fractions, respectively. After repeated chro-
matographic separations, the combined n-hexane fraction afforded
compounds 3 and 9, whilst the combined chloroform fraction yielded
compounds 2, 4, 6, 7, 10 and 11 (Fig. 1).
The ethylacetate fraction was dissolved in CHCl3/MeOH 7:3 sol-
vent system. The solution was subjected to molecular separation
using Sephadex LH-20 in a sintered column (Dimensions: 4 cm,
38 cm). The elution was isocratic using the CHCl3/MeOH 7:3 solvent
system and 50 ml eluent was collected into each of the 19 ﬂasks
used. Flasks 1 and 2 were combined according to TLC proﬁle which
showed 2 major spots. This was coded E2 (50.3 mg) and was puriﬁed
by preparative TLC to obtain compounds 3 (33.6 mg) and 2 (6.0 mg).
Flask 3 coded E3 (1.0 g) was also subjected to preparative TLC which
showed 3 bands. The bands were coded from the top as E3a (corre-
sponding to 162.3 mg material, represented by single spot on TLC),
E3b (corresponding to 149.5 mg material, represented by two majorO
O
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Fig. 1. Homoisoﬂavonoids and stspots on TLC) and E3c (corresponding to 519.2 mg material, repre-
sented by several spots on TLC). E3b was again puriﬁed by prepara-
tive TLC to yield more of E3a (109.5 mg) which was identiﬁed as
compound 2. E3c was also subjected to preparative TLC showing 5
bands which were coded E3c1 (corresponding to 10.2 mg material),
E3c2 (corresponding to 71.7 mg material), E3c3 (corresponding to
30.1 mg material), E3c4 (corresponding to 26.2 mg material) and
E3c5 (corresponding to 241. 1 mg material). TLC proﬁle of the
bands showed that they were mixtures except for E3c2 and E3c4
that displayed a single spot each. These yielded compounds 2 and 1,
respectively.
Flask 5 coded as E5 (757.1 mg) was subjected to isocratic elution
on Sephadex LH-20 using CHCl3/MeOH 7:3 solvent system. 20 ml
eluent was collected into each of 20 ﬂasks used. The ﬂasks were
combined according to TLC proﬁle as follows; 1 to 6 (26.4 mg), 7 & 8
(79.7 mg), 9 to 15 (543.6 mg), 16 to 19 (63.4 mg), and 20 (5.3 mg).
Fraction 16 to 19 only showed single spot. This gave compound 7. Frac-
tion 9 to 15, a mixture, was further subjected to preparative TLC to give
4 bands, labeled from the top as E5a (98.9 mg), E5b (64.4 mg), E5c
(173.6 mg) and E5d (132.2 mg). Band E5d showed single spot on TLC
and yielded compound 6. Band E5a, a mixture, was further puriﬁed by
preparative TLC to obtain compounds 4 (62.5 mg) and 5 (2.2 mg).
Flasks 7, 8 and 9were combined according to TLC proﬁle which showed
3 spots and was coded E9 (1.7 g). This was further puriﬁed by prepara-
tive TLC and yielded compounds 7 and 8.
2.3.2. Physical and spectroscopic data of compound 1
Yellow powder, mp. 206–208 °C, IR (neat): νmax cm−1 3354,
1695, 1610, 1233. UV (MeOH) λmax nm 394, 314, 296, 236,
[α]D = −100.1 [0.0074 g/ml], MS (EI, 70 eV): m/z (%) = 330.1
[M]+ (60), 343.0 [C19H19O6]+ (15), 327.0 [C19H20O5]+ (20), 237.0
[C12H13O5]+ (3), 209.9 [C11H13O4]+ (35), 210.9 [C10H10O5]+ (20),
211.9 [C10H11O5]+ (2), 194.9 [C10H10O4]+ (50), 166.9 [C9H10O3]+
(50), 121.0 [C8H9O]+ (85). HRMS-EI: m/z [M]+ calcd for C18H18O6,
330.1103; found 330.1102. 1H- and 13C-NMR: Table 1.
2.3.3. Bulb leaves
The washed layers of the bulbs were air-dried and ground into
powder. The powdered leaves were subjected to exhaustive and suc-
cessive extraction in chloroform (3 liter × 2), chloroform/methanol
1:1 (3 liter × 2) and methanol (3 liter × 2). The combined chloro-
form, chloroform/methanol and methanol solutions were evaporated
under reduced pressure at about 35 °C to give chloroform extractO
O
R1
R2
R3
R4
HO
MeO
OH
OH
Compounds R1 R2 R3 R4
5 OH OMe OH OMe
6 OH OMe OH OH
7 OH H OH OH
8
ilbenoid from Scilla nervosa.
Table 1
NMR data for compound 1 in MeOD (multiplicities and J values are given in Hz in
parenthesis).
1
Position δH (600 MHz) δC (150 MHz)
2 4.29 (dd, 11.4, 3.9) 68.8
4.13 (dd, 11.4, 6.9) –
3 2.71 (m) 49.9
4 – 192.9
4a – 107.8
5 – 146.7
6 – 134.4
7 – 157.1
8 6.40 (s) 95.5
8a – 155.4
9 3.09 (dd, 11.4, 2.1) 31.9
2.69 (dd, 13.1, 3.8) –
1′ – 129.1
2′, 6′ 7.08 (dd, 8.4, 1.8) 129.7
3′, 5′ 6.77 (dd, 8.4, 2.1) 114.9
4′ – 155.7
5-OMe 3.82 60.1
6-OMe – –
7-OMe – –
4′-OMe 3.91 55.3
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extract (ME, 109.6 g), respectively.
2.4. Bioassays
Compounds were assayed at various dilutions prepared from
10 mg/ml stock solutions.
2.4.1. Microorganisms and growth conditions
Neisseria gonorrhoeae (ATCC 49226, MicroBioLogics, Minnesota,
U.S.A.), Mycobacterium aurum A+ (a kind gift from Prof. Pete Smith,
Department of Pharmacology, University of Cape Town,Medical School,
Cape Town, South Africa), Escherichia coli (kindly donated by Mrs O.
Tagwa, Department of Biological Sciences, University of Botswana)
and Saccharomyces cerevisiae (common baker's yeast, GoldStar, South
Africa) were used as test organisms. N. gonorrhoeae and E. coli were
grown in Nutrient Broth (HiMedia, South Africa) at 37 °C for 48 h and
24 h respectively. M. aurum was cultured in Middlebrook 7H9 broth
(Difco Laboratories, Detroit, USA) supplemented with 10% OADC (oleic
acid/albumin/dextrose/catalase, Difco Laboratories), at 32 °C for 48 h.
S. cerevisiae was grown in aqueous solution of sucrose (50 mg/ml,
Sigma, South Africa) at 25 °C for 24 h (Mukanganyama et al., 2011).
Bacteria were maintained on agar plates at 4 °C or stored as glycerol
stocks at−80 °C.
2.4.2. Antibacterial assays
2.4.2.1. Agar diffusion. 400 μl of sterile molten agar medium was
pipetted into each well of a sterile 24-well culture plate (Corning) and
left to solidify. Bacteria were grown in their respective broth media to
a density of 1 × 106 cfu/ml. 10 μl of culture was pipetted onto each
well of the agar plates. Ethanol (60%) was the negative control and
kanamycin sulphate (100 μg/ml, Sigma) served as the positive control.
For M. aurum, the positive control was rifampicin (2 mg/ml, Sigma).
10 μl of ethanol, antibiotic or compound was pipetted onto the surface
of the agar in duplicate wells. After the agar had absorbed the liquid,
the plates were inverted and incubated in a moist chamber. Inhibition
was indicated by a clear area on the agar's surface, while visible growth
of colonies indicated no/poor inhibition.
2.4.2.2. Determination ofminimal inhibitory (MIC) andminimal bactericidal
concentration (MBC). Compounds that showed strong inhibitory resultin this preliminary screen were tested further to determine their mini-
mum inhibitory and bactericidal concentrations (MICs and MBCs re-
spectively). MICs were detected using the microplate serial dilution
method (Eloff, 1998; McGaw et al., 2008) with slight modiﬁcations.
Brieﬂy, 100 μl of compound stock solutions (10 mg/ml) was serially
diluted resulting into concentration range of 0.31 to 5000 μg/ml. The
same volume of an actively growing culture of bacteria (optical density
of 0.125 at 550 nm) was added to the different wells and plates were
incubated in a humid chamber. Susceptibility was detected by adding
40 μl of a 0.2 mg/ml stock solution ofMTT to eachwell. Following an in-
cubation period of 1 to 4 hours at 37 °C, duringwhichMTT is reduced to
a blue-purple colour in wells with no inhibition, MICs were determined
as the lowest concentrations at which growth inhibition occurred. Bac-
teriostatic effect was distinguished from bactericidal effect of the com-
pounds by taken 100 μl aliquots of bacterial suspension from each
well representing the serial dilutions described above and spread even-
ly onto respective agar plates. The concentration at which no colony
growth of microorganisms occurred was determined asminimal bacte-
ricidal concentration (MBC). Kanamycin was used as positive control.
2.4.3. Antifungal assay
Econazole nitrate (300 mg/ml) was used as a positive control for
inhibition of yeast, and ethanol (60% aqueous solution, B&M, Scientif-
ic, Cape Town, South Africa) served as the negative control. 50 μl each
of 60% ethanol, econazole or solution of test compounds was added to
a well of sterile 24-well plate (Corning). Each compound was tested
in duplicate. Dry baker's yeast (S. cerevisiae) was added to sucrose so-
lution to a concentration of 50 mg yeast/ml. 200 μl of this yeast prep-
aration was added to each well and shaken gently. The plate was
incubated for 3 h, shaking gently every 30 min. After incubation,
20 μl of the tetrazolium salt indicator MTT (3-(4,5-dimethylthiazole-
2-yl)-2,5-diphenyltetrazolium bromide, 5 mg/ml, Sigma) was added
to eachwell. The platewas shaken gently and incubated for 24 h, during
which time viable organisms reduce yellow MTT to deep purple
formazan. Colour change after incubation was recorded. Yellow colour
indicated inhibition of growth.
2.4.4. α-Glucosidase inhibition assay
Starch agar plates were prepared by boiling agar (10 g/l, HiMedia)
with potato starch (15 g/l) in distilled water. The mixture was poured
into Petri dishes (Falcon) to solidify. α-Glucosidase was extracted
from 4-day old pea shoots by grinding the shoots with phosphate
buffered saline (Oxoid). 10 μl of each compound was spotted onto
the agar along the outer edge of the plate. Each plate accommodated
10 spots. In the centre of the plate, 10 μl of 60% ethanol (negative con-
trol) and 10 μl of acarbose (4 mg/ml, Sigma) were spotted side by
side. Onto each spot, 10 μl of pea shoot extract (α-glucosidase) was
added and left to digest for 10 min. 1 ml of iodine solution (UniLAB/
Saarchem, South Africa) was then poured over the surface of the
plate and the excess was discarded. Areas where the starch was
digested by α-glucosidase appeared clear in colour, indicating no
inhibition of enzymatic activity. Spots which appeared blue (due to
iodine dying the undigested starch) indicated the inhibition of
α-glucosidase.
2.4.5. Antioxidant assay
20 μl of potassium persulphate (50 mg/ml) was added to 1 ml of
ABTS (azino-bis(ethylbenzothiazoline-sulphonic acid) diammonium
salt, Fluka, Switzerland) and left to sit for 1 h while the persulphate
oxidises ABTS to a green-black colour. The oxidised ABTS stock is
then diluted 1:19 in distilled water and 200 μl of diluted working so-
lution is pipetted into each well of a 96-well micro plate (Corning).
60% ethanol was used as a negative control and ascorbic acid
(1 mM) was used as a positive control for antioxidant activity. 10 μl
of controls or compounds were added to duplicate wells of the plate
and stirred gently using the pipette tip. Antioxidant activity was
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colourless.
Compoundswhich gave strong positive results for antioxidant activ-
ity were assayed quantitatively to determine their minimum effective
concentrations (MECs). Dilutions of the compounds and ascorbic acid
were prepared, ranging from 10 to 0.078 mg/ml. 10 μl of each dilution
was added to 190 μl diluted ABTS working solution in a microtitre
plate, as done in the qualitative assay. This gave a ﬁnal concentration
of 0.5 to 0.0039 mg/ml. The lowest concentration that showed strong
antioxidant activity (colourless solution) was taken as the MEC.
3. Results and discussion
3.1. Phytochemical analysis
The ethylacetate fraction (6.9 g) of the organic extract of the yellow
inter-bulb surfaces deposits of S. nervosawas subjected to column chro-
matography with isocratic elution (CHCl3/MeOH; 7:3, 550 ml) on
Sephadex LH-20. 10 fractions (50 ml each) were collected and further
puriﬁcation of the fractions 2, 3, 4, 5, 6 and combined 7–9 on Sephadex
LH-20 and preparative TLC yielded four 3-benzylchroman-4-ones (1–
4), four 3-benzylidenechroman-4-ones (5–7) and one stilbenoid (8).
The 1H-NMR spectrum of compound 1 gave diagnostic signals of
homoisoﬂavonoid of 3-benzylchroman-4-one structural type with
resonances of two sets of two geminal protons as double doublets at
δ4.29 and δ4.26 (J = 11.4 Hz), and δ4.13 and δ4.09 (J = 11.4 Hz)
were assigned to protons at C-2. These protons showed HMQC corre-
lations to C-2 at δ69.0. The second set at δ3.09 and δ3.05 (J =
11.4 Hz), and δ2.69 and δ2.65 (J = 11.4 Hz) were assigned to protons
at C-9. These protons showed HMQC correlations to C-9 at δ31.9. Both
sets of geminal protons showed COSY correlations to a multiplet sig-
nal at δ2.71 integrated as one proton. This proton showed HMQC cor-
relation to a carbon at δ48.5 and was assigned to proton at C-3. The
1H-NMR spectrum of compound 1 also showed an AA′BB′ system in
its ring B where two signals, each occurred as doublet at δ6.77 and
δ7.08 (J = 8.4 Hz), integrated as two protons each and were assigned
to the 4′-substituted ring B. There were resonances at δ3.82 and
δ3.91, each integrated as three protons which indicated two methoxy
groups in the molecule. The only singlet signal in the aromatic region
at δ6.40, integrated as one proton, was assigned to H-8 based on its 2J
HMBC correlations with C-8a and C-7 and also its 3J HMBC correla-
tions with C-4a and C-6.
The HREIMS of compound 1, the new homoisoﬂavonoid, showed a
molecular ion peak at m/z 330.1102 consistent with a molecular
formula C18H18O6, which was supported by the analyses of 13C- and
DEPT135 NMR spectra. In the HREIMS, an ion at m/z 121.0636
[C8H9O]+ indicated that one of the methoxy groups was on ring B and
this was supported by the 3J HMBC correlations of themethoxy protons
(δ3.91) with C-4′ at δ155.4 and also the 2J and 3J HMBC correlations of
H-3′ and H-2′ respectively with C-4′ as shown in Fig. 2. The ion peaks
at m/z 209.0605 [C10H9O5]+ and 208.0729 [C10H8O5]+ were due to
cleavage between C-3 and C-9. The ion peaks at m/z 181.0435O O
O O
HO
HO
H
H
H
H
H
C H
H
H
C
H
HH
H
H
H H
Fig. 2. HMBC correlations of compound 1.[C8H5O5]+ and 180.0729 [C8H4O5]+ were assumed to be formed by the
expected retro Diels-Alder fragmentation and 181.0435 [C9H9O4]+ as a
result of loss of carbon monoxide (Famuyiwa et al., 2012) which
indicated the second methoxy group on ring A. The position of the
methoxy group in ring A was conﬁrmed by 3J HMBC correlations of the
methoxy protons (δ3.82) with C-5 at δ146.8. Thus compound 1 was
identiﬁed as 3-(4′-methoxybenzyl)-6,7-dihydroxy-5-methoxychroman-
4-one. Measurement of the speciﬁc optical rotation of compound 1 in
MeOH (HPLC grade) at 20 °C gave a result of −100.1°. By comparison
with literature results R conﬁguration was assigned to compound 1 at
C-3 (Amschler et al., 1996; O'Donnell et al., 2006).3.2. Bioactivity analysis
The crude extract of the yellow deposits, the fractions of these ex-
udates and subsequently isolated compounds, as well as the extracts
of the washed bulb leaves were subjected to various qualitative
assays prescreening for antioxidant, antimicrobial (S. cerevisiae,
Escherischia coli, M. aurum and N. gonorrhoeae) and α-glucosidase in-
hibitory activities (Table 2). S. cerevisiae (baker's yeast) was included
in this study as a model organism to screen for anti-fungal activities.
Gram-negative E. coli is responsible for many food-borne diseases
resulting in diarrhea and dysentery (Evans and Evans, 1996).
M. aurum is a fast-growing, non-pathogenic mycobacterium which
has very similar drug susceptibility characteristics as Mycobacterium
tuberculosis (Chung et al., 1995; Gupta et al., 2009), the causative
agent of tuberculosis which constitutes one of the main opportunistic
infections in immune-compromised health content. N. gonorrhoeae is
the causative agent for gonorrhea.
Only the chloroform extract (CE) showed signiﬁcant anti-M. aurum
activity. Weak anti-M. aurum activity of the crude extract of the yel-
low deposits (AC) was retained in the hexane fraction (HF) of exu-
dates but was lost during further fractionation and could not be
attributed to any of the isolated compounds (Table 2). None of the
extracts and fractions signiﬁcantly inhibited E. coli growth (possibly
due to a low concentration of compounds in the initial extracts and
fractions), but compounds 2 and 11 isolated from the yellow de-
posits displayed signiﬁcant anti-E. coli activity in the qualitative
screening. The crude extract of the yellow deposits and the fractions
there from except the methanol fraction showed anti-gonococcal
activity in the qualitative screening which could be attributed to
compound 8 and to a lesser extent to compound 6 isolated from the
yellow deposits. Compound 8, a stilbenoid, belongs to the group of
compounds known as phytoalexins which are produced by plants in
times of environmental stress or pathogenic attack (Soleas et al.,
1995). The anti-gonoccoccal activity of the other fractions from the yel-
low deposits could be a result of synergistic effects of compounds in the
fractions. Only the crude extract of the yellow deposits (AC) inhibited
the growth of S. cerevisiae, but this activity was lost during consecutive
fractionation and isolation of compounds.
In order to quantify the efﬁcacy of antibacterial activities, the min-
imal inhibitory and minimal bactericidal concentrations (MICs and
MBCs, respectively) of samples were determined using the micro-
plate serial dilution method (Eloff, 1998) (Table 3). The MICs of
extracts and fractions varied between 156.25 and 1250.00 μg/ml
which represents only weak activities. Anti-E. coli activities of com-
pounds 2 and 11 could be considered to be weak since their MICs
turned out to be low with a value of 1250.00 μg/ml compared to the
standard (Kanamycin) with a value of 1.22 μg/ml. Anti-M. aurum
activity of chloroform extract (CE) could be considered to be weak
with MIC value of 625.00 μg/ml as compared to the control (Rifampi-
cin) with MIC value of 0.61 μg/ml. Anti-gonococcal MIC of compound
8 is strong with a value of 19.53 μg/ml, compared to the MIC of the
control of 78.13 μg/ml, but with higher MBC of 312.50 μg/ml. An ex-
tract (CE) and fractions (HF and EF) displayed bacteriostatic activity
Table 2
Qualitative pre-screening of extracts, fractions and compounds for different bioactivities.
Bioassay
Sample Antioxidant activity α-Glucosidase inhibition Anti-E. coli Anti-M. aurum Anti-N. gonorrhoeae Anti-S. cerevisiae
AC +++ − − ++ +++ +++
HF +++ + − ++ +++ −
CF +++ − + + +++ −
EF +++ − + − +++ −
MF + ++ − − − −
CE +++ + − +++ +++ −
CM ++ +++ − − − −
ME + +++ − − + −
1 +++ − ++ − − −
2 +++ ++ +++ − + −
3 − ++ + − + −
4 +++ − ++ − + −
6 +++ − ++ − ++ −
7 − + ++ − - −
8 +++ − + − +++ −
9 − + − − − −
10 ++ ++ − − − −
11 + − +++ − + −
−: No inhibition/activity; +: very weak inhibition/activity; ++: weak inhibition/activity; +++: signiﬁcant inhibition/activity.
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active agents.
Researchers have proposed inhibition of nutrient uptake as a mech-
anism for bacterial inhibition by isoﬂavonoids. Studies have shown that
isoﬂavonoids hamper the uptake of glucose and thymidine by bacterial
cells, thereby achieving a bacteriostatic, but not bactericidal effect (Sato
et al., 2003). Further studies have suggested that isoﬂavonoids may in-
hibit disaccharide peptide production in bacteria, which would again
offer a suitable explanation for the inhibitory activity reported here.
According to EUCAST's published MIC breakpoints for 2013, there are
no speciﬁcally determined MIC cutoffs for isoﬂavonoid antimicrobials.
However, other classes of antimicrobials are cited as having clinically
acceptable MIC in the following ranges: 3 × 10−5–6.4 × 10−2 mg/ml
for N. gonorrhoeae, 5 × 104–6.4 × 10−2 mg/ml for E. coli, and
2.5 × 104–1.6 × 10−2 mg/ml for other bacteria species (European
Committe on Antimicrobial Susceptibility Testing, EUCAST, 2012).
A one-sided Student's t-testwas performed (at 95% conﬁdence interval)
to compare the observed MICs with the upper limit of the EUCAST
breakpoints. By this statistical test, all the MICs reported here were
signiﬁcantly higher than the acceptable cutoff, except for compound 8
against N. gonorrhoeae. This is an indication that compound 8 might
have potential as a therapeutical agent for the management of
gonorrhea.
Two of the extracts fromwashed bulb leaves, CM andME, displayed
signiﬁcant α-glucosidase inhibitory activity. Fractions and compounds
isolated from the exudates did not display inhibitory activity here.
α-Glucosidase inhibitors have attracted interest as potential therapeutic
agents as anti-diabetics (Tundis et al., 2010) or as suppressors of theHIVTable 3
MICs and MBCs of samples against three microorganisms.
Organism inhibited/killed Sample MIC (μg/ml) MBC (μg/ml)
Neisseria gonorrhoeae AC 312.50 2500.00
HF 625.00 –
CF 156.25 312.50
EF 312.50 156.25
CE 156.25 –
Compound 8 19.53 312.50
Kanamycin 78.13
Mycobacterium aurum CE 625.00 –
Rifampicin 0.61
Escherichia coli Compound 2 1250.00 1250.00
Compound 11 1250.00 1250.00
Kanamycin 1.22replication cycle mainly at the entry stage (Robina et al., 2004). The
crude extract of the yellow deposits of S. nervosa (AC), as well as the
fractions (HF, CF, and EF), with the exception of the methanol fraction
(MF), showed strong antioxidant activity which was retained in com-
pounds 1, 2, 4, 6 and 8 whose minimal effective concentrations
(MECs) were determined (Table 4). MECs varied within a range of
3.91 μg/ml to 125.00 μg/ml with compounds 2 and 8 displaying the
lowest MECs values of 3.91 μg/ml each, respectively, followed by com-
pound 1 with a MEC of 7.81 μg/ml, which is considerably lower than
the MEC of 15.62 μg/ml of ascorbic acid which was used as standard
in this study.
For compounds 4 and 6, a one-sided Student's t-test was per-
formed at 95% conﬁdence interval and the MECs of these two com-
pounds were determined to be signiﬁcantly higher than that of the
standard ascorbic acid, which implies a lower potential as antioxidant
drug candidates. The strong activities reported here for compounds 1
and 2 are consistent with previous reports of antioxidant activities of
other 3-benzylchromanones. This class of compounds is known to con-
tain potent antioxidants, especially compounds having hydroxyl groups
(Rao et al., 2008). The presence of hydroxyl groups on compounds 1
and 2, then, would explain the stronger antioxidant activity of these
compounds compared to the other assayed benzylchromanones (com-
pounds 3 and 9), which are methoxy-substituted and lack hydroxyl
groups. Similarly for stilbenoids such as compound 8, antioxidant activ-
ity has been positively correlated to the number of hydroxyl substitu-
ents. This is because compounds which are able to form stable radicals
tend tomake promising antioxidants, and the hydroxyl groupsmay sta-
bilize (by resonance) the radical intermediate formed by the stilbenoids
(Chai et al., 2012). This would support the ﬁnding that compound 8,
with three hydroxyl groups, showed the lowestMEC. The comparatively
stronger antioxidant activities of the investigated homoisoﬂavonoids
are in agreementwith the generally well-known antioxidant propertiesTable 4
Minimum effective concentrations (MECs) of the 5 com-
pounds showing antioxidant activity.
Compound MEC (μg/ml)
1 7.81
2 3.91
4 125.00
6 62.50
8 3.91
Ascorbic acid 15.62
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Kerth, 2011).
The most striking difference between bioactivity proﬁles of exu-
date fractions and extracts from washed bulb leaves is the antifungal
activity which was present only in the crude extract of exudates.
However, the loss of this activity after fractionation suggested that
the activity may be due to synergistic effects between compounds
isolated in different fractions. It should also be noted that washed
bulb leaves, chloroform/methanol and methanol extracts, showed
α-glucosidase inhibition, which was not displayed by any of the exu-
dates extract and fractions. Aside from these, there was no outstand-
ing difference between the bioactivity proﬁles of the exudate extracts
and those from washed bulb leaves.
4. Conclusion
This report describes a new homoisoﬂavonoid isolated from the yel-
low deposits of the inter-bulb surfaces of S. nervosa, thus conﬁrming
that exudates of the bulbs are valuable sources for new compounds. In
fact, themajority of homoisoﬂavonoidmetaboliteswere found between
the bulb leaves.
The screening of antioxidant, α-glucosidase inhibitory and antimi-
crobial activities of the exudates extract, fractions and subsequently
isolated compounds revealed that the bulbs of S. nervosa may have
a major health application as antioxidants, while antimicrobial prop-
erties tended to be weak. Only the stilbenoid (8) isolated from the
bulb exudates reported in this study was found to display MIC against
gonococci below the EUCAST break-off point indicating its potential as
an anti-gonococcal therapeutic. The bioactivity pattern of exudate and
washed bulb leaves extracts overlapped to a considerable degree but
revealed the yellow deposits as sources of diverse antimicrobials
though the overall activities tended to be low. Some of the
homoisoﬂavonoids described in this study could be identiﬁed as
the antimicrobial principles. The exudates furthermore constituted
the only source of antifungal active principle(s) which attributes a
broader antimicrobial spectrum to the exudates compared to the
extracts of the bulbs without yellow deposits that were investigated.
Furthermore, this study emphasizes the fact that detected biolog-
ical activities in crude extracts cannot always be attributed to ﬁnal
isolated compounds and that it is important for the evaluation of re-
alistic antimicrobial properties not to rely on minimal inhibitory con-
centrations only, but to determine whether the antimicrobial extract,
fraction or compound constitutes a bacteriocidal or bacteristatic
agent. Minimal bactericidal concentrations (MBCs), such as identiﬁed
in this study, are in many cases signiﬁcantly higher than minimal
inhibitory concentration (MICs) and failing to consider this may
lead to a substantial overestimation of the efﬁcacy of the investigated
sample.
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